ARES(ARES)
ARES
Q4 2026 EPS Estimate
$1.34
Nov 2, 2026 · Reports before open
Revenue Estimate
$1.25B
FY2026E EPS$5.89
FY2027E EPS$7.29
Analyst Sentiment
Wall St. Consensus
Buy22 analysts·High coverage
72
Score
18 Buy (82%)4 Hold (18%)0 Sell (0%)
Rating Breakdown
Strong Buy
15%
Buy
1777%
Hold
418%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$134.00
-7.5%
Consensus
$148.00
+2.1%
Bull
$168.00
+15.9%
12-Month Target Range22 analysts
$134.00$148.00$168.00
Current $144.92Consensus
Current Price
$144.92
Upside to Consensus
$3.08
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+19.55%
EPS+23.82%
FY2028
Rev+9.28%
EPS+17.66%
FY2029
Rev+60.30%
EPS+12.96%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $5.64B | $6.74B | $7.37B | $11.81B |
| Low | $5.32B | $6.42B | $7.25B | $11.50B |
| High | $5.85B | $6.98B | $7.48B | $12.06B |
| EBITDA Avg | $2.74B | $3.28B | $3.58B | $5.74B |
| Low | $2.59B | $3.12B | $3.53B | $5.59B |
| High | $2.84B | $3.39B | $3.64B | $5.86B |
| EBIT Avg | $2.42B | $2.90B | $3.17B | $5.08B |
| Low | $2.29B | $2.76B | $3.12B | $4.95B |
| High | $2.51B | $3.00B | $3.22B | $5.19B |
| Net Income Avg | $1.29B | $1.57B | $2.16B | $2.11B |
| Low | $1.23B | $1.47B | $1.72B | $2.03B |
| High | $1.35B | $1.67B | $2.17B | $2.16B |
| EPS Avg | $5.89 | $7.29 | $8.57 | $9.68 |
| Low | $5.67 | $6.76 | $7.92 | $9.36 |
| High | $6.19 | $7.70 | $9.98 | $9.96 |
| Analysts (Rev / EPS) | 4 / 8 | 5 / 11 | 2 / 4 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.30B | $1.90B | $1.47B | $1.49B | $1.55B | $2.36B | $1.57B | $1.59B |
| Low | $1.21B | $1.79B | $1.41B | $1.43B | $1.49B | $2.26B | $1.51B | $1.52B |
| High | $1.38B | $1.96B | $1.52B | $1.54B | $1.60B | $2.43B | $1.62B | $1.64B |
| EBITDA Avg | $633M | $923M | $715M | $725M | $753M | $1.15B | $765M | $772M |
| Low | $589M | $870M | $686M | $696M | $723M | $1.10B | $735M | $741M |
| High | $673M | $952M | $737M | $747M | $776M | $1.18B | $788M | $795M |
| EBIT Avg | $560M | $817M | $632M | $642M | $666M | $1.01B | $677M | $683M |
| Low | $521M | $770M | $607M | $616M | $639M | $973M | $650M | $656M |
| High | $595M | $842M | $652M | $661M | $686M | $1.04B | $697M | $704M |
| Net Income Avg | $312M | $445M | $351M | $364M | $387M | $543M | $388M | $420M |
| Low | $294M | $406M | $333M | $345M | $367M | $515M | $368M | $398M |
| High | $342M | $480M | $365M | $378M | $402M | $565M | $403M | $436M |
| EPS Avg | $1.38 | $1.97 | $1.55 | $1.61 | $1.71 | $2.40 | $1.71 | $1.86 |
| Low | $1.30 | $1.80 | $1.47 | $1.52 | $1.62 | $2.28 | $1.62 | $1.76 |
| High | $1.51 | $2.12 | $1.61 | $1.67 | $1.78 | $2.49 | $1.78 | $1.93 |
| Analysts (Rev / EPS) | 3 / 8 | 3 / 7 | 1 / 2 | 1 / 2 | 1 / 2 | 1 / 5 | 1 / 6 | 1 / 5 |